ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 12.89% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | -26.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.55% |
| Dec 31, 2025 | 4.73% |
| Sep 30, 2025 | 32.20% |
| Jun 30, 2025 | 45.01% |
| Mar 31, 2025 | 62.66% |
| Dec 31, 2024 | -127.92% |
| Sep 30, 2024 | 24.08% |
| Jun 30, 2024 | 12.83% |
| Mar 31, 2024 | 5.68% |
| Dec 31, 2023 | 55.63% |
| Sep 30, 2023 | 9.87% |
| Jun 30, 2023 | 28.79% |
| Mar 31, 2023 | -2.96% |
| Dec 31, 2022 | -5.96% |
| Sep 30, 2022 | -29.42% |
| Jun 30, 2022 | -12.25% |
| Mar 31, 2022 | -19.57% |
| Dec 31, 2021 | -37.94% |
| Sep 30, 2021 | 27.24% |
| Jun 30, 2021 | -10.55% |